PL3373996T3 - Sposób wytwarzania, zastosowania i dostarczania aktywowanych komórek macierzystych - Google Patents

Sposób wytwarzania, zastosowania i dostarczania aktywowanych komórek macierzystych

Info

Publication number
PL3373996T3
PL3373996T3 PL16865155.2T PL16865155T PL3373996T3 PL 3373996 T3 PL3373996 T3 PL 3373996T3 PL 16865155 T PL16865155 T PL 16865155T PL 3373996 T3 PL3373996 T3 PL 3373996T3
Authority
PL
Poland
Prior art keywords
delivery
generation
stem cells
activated stem
activated
Prior art date
Application number
PL16865155.2T
Other languages
English (en)
Inventor
John Scott Strachan
Todd Frank OVOKAITYS
Original Assignee
Ovokaitys, Todd F.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ovokaitys, Todd F. filed Critical Ovokaitys, Todd F.
Publication of PL3373996T3 publication Critical patent/PL3373996T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
    • C12N2529/10—Stimulation by light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
PL16865155.2T 2015-11-12 2016-11-11 Sposób wytwarzania, zastosowania i dostarczania aktywowanych komórek macierzystych PL3373996T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562254220P 2015-11-12 2015-11-12
US201662321781P 2016-04-13 2016-04-13
PCT/US2016/061673 WO2017083755A1 (en) 2015-11-12 2016-11-11 Methods and systems for generation, use, and delivery of activated stem cells

Publications (1)

Publication Number Publication Date
PL3373996T3 true PL3373996T3 (pl) 2024-02-26

Family

ID=58695474

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16865155.2T PL3373996T3 (pl) 2015-11-12 2016-11-11 Sposób wytwarzania, zastosowania i dostarczania aktywowanych komórek macierzystych

Country Status (23)

Country Link
EP (2) EP4245361A3 (pl)
JP (1) JP2018535217A (pl)
KR (1) KR20180094889A (pl)
CN (1) CN108472417A (pl)
AU (1) AU2016353347B2 (pl)
BR (1) BR112018009741A8 (pl)
CA (1) CA3004614A1 (pl)
CR (1) CR20180319A (pl)
DK (1) DK3373996T3 (pl)
EA (1) EA038728B1 (pl)
ES (1) ES2961525T3 (pl)
FI (1) FI3373996T3 (pl)
HR (1) HRP20231386T1 (pl)
HU (1) HUE063831T2 (pl)
LT (1) LT3373996T (pl)
MX (2) MX2018005997A (pl)
MY (1) MY199010A (pl)
PL (1) PL3373996T3 (pl)
PT (1) PT3373996T (pl)
RS (1) RS64809B1 (pl)
SI (1) SI3373996T1 (pl)
SM (1) SMT202300379T1 (pl)
WO (1) WO2017083755A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
WO2015187974A1 (en) 2014-06-06 2015-12-10 Ovokaitys Todd Frank Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
AU2021397627A1 (en) * 2020-12-08 2023-07-20 Todd Frank OVOKAITYS Methods and systems for increased production of stem cells
CN117769694A (zh) * 2021-07-29 2024-03-26 元平台技术有限公司 用于选择智能眼镜中的摄像头的视场的用户接口
KR102925697B1 (ko) * 2025-10-23 2026-02-10 주식회사 와이앤제이바이오 뇌졸중 환자의 상지기능 개선을 위한 광치료장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549483A (ja) * 1991-08-08 1993-03-02 Hitachi Ltd 生細胞レ−ザ照射方法
GB9920351D0 (en) * 1999-08-28 1999-11-03 Strachen John S Sparse constructive node stimulation of cell surface molecular resonance in vivo
US9211332B2 (en) * 2005-07-21 2015-12-15 The Invention Science Fund I, Llc Selective resonance of bodily agents
AU2009100401A4 (en) * 2009-04-30 2009-06-04 Gl Holdings Inc Bv Method of extracting and activating adipose-derived stem cells
JP2012100599A (ja) * 2010-11-11 2012-05-31 Yohei Tanaka 幹細胞活性化装置
US20140303546A1 (en) * 2011-06-24 2014-10-09 University Of Miami Laser assisted delivery of functional cells, peptides and nucleotides
TW201500549A (zh) 2013-06-19 2015-01-01 Univ Taipei Medical 促進幹細胞方向性移動之方法及裝置
JP6377929B2 (ja) * 2014-03-27 2018-08-22 株式会社吉田製作所 幹細胞培養装置、および幹細胞培養方法
CN107072716A (zh) * 2014-05-30 2017-08-18 托德.F.奥沃凯蒂斯 用于产生和使用活化的干细胞的方法和系统

Also Published As

Publication number Publication date
HUE063831T2 (hu) 2024-02-28
EA201890909A1 (ru) 2018-12-28
HRP20231386T1 (hr) 2024-03-01
KR20180094889A (ko) 2018-08-24
JP2018535217A (ja) 2018-11-29
EP4245361A3 (en) 2023-11-22
DK3373996T3 (da) 2023-11-06
EP3373996A4 (en) 2019-10-16
EP4245361A2 (en) 2023-09-20
SI3373996T1 (sl) 2024-04-30
CN108472417A (zh) 2018-08-31
MY199010A (en) 2023-10-09
AU2016353347A1 (en) 2018-05-24
CR20180319A (es) 2019-01-09
SMT202300379T1 (it) 2024-01-10
AU2016353347B2 (en) 2021-09-02
WO2017083755A1 (en) 2017-05-18
CA3004614A1 (en) 2017-05-18
BR112018009741A8 (pt) 2019-02-26
EP3373996B1 (en) 2023-08-02
ES2961525T3 (es) 2024-03-12
MX2018005997A (es) 2018-09-06
BR112018009741A2 (pt) 2018-11-06
PT3373996T (pt) 2023-11-13
LT3373996T (lt) 2023-11-27
RS64809B1 (sr) 2023-12-29
MX2024001653A (es) 2024-05-20
FI3373996T3 (fi) 2023-11-03
EP3373996A1 (en) 2018-09-19
EA038728B1 (ru) 2021-10-11

Similar Documents

Publication Publication Date Title
IL273507A (en) Methods, devices and systems for administering active substances through the lungs
PT3170842T (pt) Célula efetora imunológica de cld18a2 direcionado e método de preparação e utilização da mesma
GB201410970D0 (en) Improved vaporizer and vaporizing method
EP3124432A4 (en) Hydrogen generation system and hydrogen generation method
GB201410270D0 (en) Cell delivery system and method
IL251852A0 (en) Systems and methods for treating the heart valve
SG11201610363SA (en) System and method for heart valve anchoring
EP3148469A4 (en) Method and system for generation and use of activated stem cells
EP3118307A4 (en) Activator for mesenchymal stem cells, activated mesenchymal stem cells, and method for producing same
PL3586821T3 (pl) Kompozycje stymulujące komórki macierzyste i sposoby
EP2990102A4 (en) PRESSURE INCREASE SYSTEM, AND METHOD FOR INCREASING GAS BODY PRESSURE
SI3373996T1 (sl) Postopek za tvorbo, uporabo in dovajanje aktiviranih matičnih celic
EP3383182C0 (en) METHODS FOR PRODUCING FUNCTIONAL HEMATOPOIETIC STEM CELLS
PT3305675T (pt) Embalagem
EP3265556A4 (en) Methods for making neural stem cells and uses thereof
EP3159790A4 (en) Program generation device, program generation method, and program
IL250281A0 (en) Hair transplantation systems, devices and methods
EP3156897A4 (en) Program generation device, program generation method and program
PL2921420T3 (pl) Pojemnik na środek czynny i sposób jego wytwarzania
LT3157918T (lt) 2-aril-4-hidroksi-1,3-tiazolo dariniai, tinkami naudoti kaip trpm8-inhibitoriai neuralgijos, skausmo, lėtinės obstrukcinės plaučių ligos (lopl) ar astmos gydymui
SG10201403640XA (en) Stem cells
SG11201800358PA (en) Capillary Vessel-Derived Stem Cells, Use Of The Same, And, Method For Producing The Same
GB2529398B (en) Fuel, system and method
EP3194651C0 (en) METHOD AND INSTALLATION FOR THE PRETREATMENT OF BIOMASS
PT3236877T (pt) Disposição que compreende um implante e um processo